Here's the live share price of Divi's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Divi's Laboratories | -0.95 | 9.08 | 8.92 | 7.56 | 4.66 | 28.05 | 10.94 |
| Sun Pharmaceutical Industries | 1.17 | 13.20 | 8.82 | 5.91 | 8.86 | 26.25 | 22.25 |
| Torrent Pharmaceuticals | 1.47 | 8.23 | 3.77 | 21.26 | 36.06 | 38.90 | 26.92 |
| Cipla | -2.83 | 13.39 | 5.42 | -7.50 | -5.67 | 14.76 | 8.57 |
| Dr. Reddy's Laboratories | 1.24 | 8.05 | 0.92 | 5.98 | 7.70 | 13.96 | 4.80 |
| Lupin | 1.30 | -1.06 | 1.88 | 12.74 | 14.61 | 43.43 | 13.49 |
| Zydus Lifesciences | 4.53 | 11.56 | 14.13 | 12.08 | 16.46 | 26.96 | 11.08 |
| Mankind Pharma | 1.82 | 14.17 | 22.51 | 11.76 | -1.04 | 23.48 | 11.97 |
| Aurobindo Pharma | 2.44 | 11.16 | 34.47 | 28.30 | 28.45 | 36.89 | 8.82 |
| Laurus Labs | 2.62 | 21.13 | 32.74 | 38.10 | 126.11 | 62.97 | 22.55 |
| Biocon | 2.59 | 18.98 | 10.88 | 8.48 | 26.19 | 21.43 | 2.37 |
| Glenmark Pharmaceuticals | 1.91 | 6.81 | 17.03 | 29.26 | 65.65 | 57.95 | 31.46 |
| Alkem Laboratories | -1.44 | -3.50 | 0.12 | -3.55 | 2.26 | 19.10 | 12.87 |
| Abbott India | 0.89 | 9.32 | 4.84 | -6.08 | -11.65 | 9.12 | 11.57 |
| Anthem Biosciences | -6.46 | 3.68 | 10.02 | 20.55 | 4.83 | 1.58 | 0.95 |
| Ipca Laboratories | 4.70 | 12.17 | 12.19 | 14.76 | 12.69 | 34.39 | 8.28 |
| Ajanta Pharma | -3.41 | 12.70 | 5.81 | 26.79 | 19.41 | 33.88 | 19.58 |
| GlaxoSmithKline Pharmaceuticals | -4.29 | -4.65 | -12.26 | -7.32 | -22.46 | 21.23 | 9.61 |
| Gland Pharma | 23.58 | 31.41 | 29.94 | 29.54 | 48.93 | 37.88 | -5.91 |
| J B Chemicals & Pharmaceuticals | 1.87 | 9.28 | 6.38 | 26.12 | 30.34 | 30.69 | 24.69 |
Source: Dion Global
Over the last one year, Divi's Laboratories has gained 4.66% compared to peers like Sun Pharmaceutical Industries (8.86%), Torrent Pharmaceuticals (36.06%), Cipla (-5.67%). From a 5 year perspective, Divi's Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (22.25%) and Torrent Pharmaceuticals (26.92%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 6,844.23 | 6,853.26 |
| 10 | 6,769.48 | 6,785.61 |
| 20 | 6,611.38 | 6,651.11 |
| 50 | 6,308.65 | 6,444.1 |
| 100 | 6,297.1 | 6,360.55 |
| 200 | 6,300.09 | 6,282.71 |
Source: Dion Global
In the latest quarter, Divi's Laboratories remained same as its previous close in promoter holding, while DII stake decreased to 19.22%, FII holding rose to 20.29%, and public shareholding moved down to 8.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 33,00,000 | 2.57 | 2,145.83 | |
| 20,32,024 | 2.47 | 1,321.32 | |
| 18,01,066 | 1.17 | 1,171.14 | |
| 15,70,000 | 2.22 | 1,020.89 | |
| 10,02,547 | 2.07 | 651.91 | |
| 9,20,000 | 2.59 | 598.23 | |
| 8,89,114 | 5.36 | 578.15 | |
| 8,88,857 | 0.55 | 577.98 | |
| 8,61,190 | 1.08 | 559.99 | |
| 8,50,754 | 6.61 | 553.2 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 16, 2026, 12:39 AM IST IST | Divi's Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 14, 2026, 05:40 AM IST IST | Divi's Laboratories - Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Re |
| Apr 06, 2026, 08:48 PM IST IST | Divi's Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 21, 2026, 09:47 PM IST IST | Divi's Laboratories - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulatio |
| Feb 14, 2026, 08:50 PM IST IST | Divi's Laboratories - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Source: Dion Global
Divi's Laboratories Ltd. is a Public Limited Listed company incorporated on 12/10/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC011854 and registration number is 011854. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 9198.00 Cr. and Equity Capital is Rs. 53.00 Cr. for the Year ended 31/03/2025.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Divi's Laboratories is ₹6,856.20 as on May 21, 2026.
The Divi's Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Divi's Laboratories is ₹182,010.57 Cr as on May 21, 2026.
Today’s highest and lowest price of Divi's Laboratories are ₹6,919.00 and ₹6,828.50.
The 52-week high/low is the highest and lowest price at which Divi's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Divi's Laboratories is ₹7,077.70 and 52-week low of Divi's Laboratories is ₹5,637.50 as on May 21, 2026.
The Divi's Laboratories has shown returns of -0.54% over the past day, 9.08% for the past month, 8.92% over 3 months, 4.66% over 1 year, 28.05% across 3 years, and 10.94% over 5 years.
P/E ratio of and PB ratio of Divi's Laboratories are 73.42 and 11.38 on May 21, 2026. While the company gives a dividend yield of 0.44 per annum.
Source: Dion Global